Graig Springer's most recent trade in Hoth Therapeutics Inc was a trade of 70,000 Options done . Disclosure was reported to the exchange on Jan. 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2025 | 70,000 | 70,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 48,000 | 48,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Aug 2024 | 25,000 | 25,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 100,000 | 100,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 25,000 | 25,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 20,000 | 20,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 7,500 | 7,500 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 250,000 | 250,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2022 | 40,000 | 40,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 150,000 | 150,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 33,000 | 33,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 45,000 | 45,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2020 | 15,000 | 15,000 | - | - | Options | |
Hoth Therapeutics Inc
|
Graig Springer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Apr 2020 | 3,333 | 3,333 (0%) | 0% | - | Common Stock |